COMMUNIQUÉS West-GlobeNewswire

Carequality Seeks Community Input As It Expands Governance to FHIR
11/10/2018
VIENNA, Va., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Carequality , a national-level, interoperability trusted exchange framework , is actively seeking input from the healthcare community as it adds support for FHIR-based [...]
ADMA Biologics Provides Regulatory Update for BIVIGAM®
11/10/2018
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 11, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Teladoc Health Announces Availability of Best Doctors Oncology Insight in Canada
11/10/2018
Now available to Sun Life Financial clients, Oncology Insight provides patients facing cancer access to the world’s leading oncologists, backed by recommended treatment options from IBM Watson for Oncology TORONTO, Oct [...]
Cerner to Release Third Quarter 2018 Earnings Results October 25
11/10/2018
KANSAS CITY, Mo., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its third quarter 2018 earnings results after the market closes Thursday, Oct. 25. Following the [...]
numares’ ground breaking method to precisely determine glomerular filtration rate presented at ASN Kidney Week
11/10/2018
REGENSBURG, Germany, Oct. 11, 2018 (GLOBE NEWSWIRE) -- numares along with clinical study partners from three European medical centers will be presenting their results on a novel method for the accurate assessment of [...]
HempAmericana Unveils New Web Presence Ahead of Expanded Commercial Operations
11/10/2018
NEW YORK, Oct. 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce the official launch of the Company’s new website ( www.hempamericana [...]
Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatment with ARIKAYCE® (amikacin liposome inhalation suspension)
11/10/2018
BRIDGEWATER, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that the Company [...]
Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD
11/10/2018
MINNEAPOLIS, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Scythian Biosciences Announces Major Milestone in U.S. Expansion
11/10/2018
Florida Department of Health Approves CannCure’s Purchase of 60% of the Equity of 3 Boys Farms Including the License to Operate as a Medical Marijuana Treatment Center in Florida 3 Boys Farms Gets Former Incredibles [...]
Allscripts to release third-quarter 2018 financial results November 1
11/10/2018
CHICAGO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended September 30, 2018, after the close of stock market hours on [...]
Data from Celtaxsys’ Acebilustat Phase 2 Trial addressing Lung Inflammation in CF Patients to be presented at the North American Cystic Fibrosis Conference
11/10/2018
ATLANTA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Full results from the recently completed Phase 2 trial (EMPIRE-CF) of Celtaxsys’ acebilustat will be presented at the North American Cystic Fibrosis Conference to be held [...]
Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification
11/10/2018
DANVERS, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, November 1, 2018, the Company will release financial results for the second quarter of fiscal 2019. The Company [...]
iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis
11/10/2018
Results demonstrate unprecedented improvements in clinical performance and reading times, validating the substantial benefits of artificial intelligence when used with 3D mammography Company to showcase latest [...]
Spero Therapeutics Receives QIDP Designation from the U.S. FDA for the Development of SPR206
11/10/2018
CAMBRIDGE, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]
Sirona Biochem to Present at the 2018 Arctic Circle Assembly
11/10/2018
VANCOUVER, British Columbia, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (the “ Company ”) announced today that Chief Scientific Officer, Dr. Geraldine Deliencourt-Godefroy will [...]
Dermavant Sciences to Present Tapinarof Phase 2b Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference
11/10/2018
BASEL, Switzerland, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that two abstracts containing Phase 2b data on patient-reported outcomes in [...]
Biogen Advances Research to Improve Outcomes for Patients With Multiple Sclerosis
11/10/2018
Evidence supports potential of serum neurofilament light (sNfL) as clinically useful biomarker in MS; Biogen and Siemens Healthineers collaborate to develop sNfL blood test Real-world data add to the large body of [...]
ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson’s Disease
11/10/2018
Unique discovery platform generates new antibody candidates that block a root cause of Parkinson’s Disease TORONTO and CAMBRIDGE, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: [...]
Pain Therapeutics Announces Appointment of Chief Financial Officer
11/10/2018
AUSTIN, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that Mr. Eric Schoen will join its management team as Chief Financial Officer, [...]

Pages